Neurogenetics of emotional reactivity to stress in animals by Chaouloff, Francis
he influence of genetic factors on the nature and
intensity of stress responses has been widely demon-
strated in several animal species
1 and in humans.
2 This
genetic component may be directly responsible for the
large interindividual variation often observed for this kind
of trait,or,as indicated by recent findings,it may provoke
variations through interaction between genotype and
environment,including postnatal environment.
3The use
of intraspecific groups of animals that differ in their
genetic backgrounds and/or their responses to environ-
mental challenges has gained more and more interest.The
selection of divergent rat or mouse strains that differ in
their behavioral responses to well-defined stressors,such
368
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as the Maudsley strains of rat,
4 provides an example of
such a strategy.Interestingly,the use of divergent strains
of rats to understand the physiology (including the neuro-
chemistry) of stress responses has recently been comple-
mented by genetic studies of quantitative trait loci,lead-
ing to a precise genomic location underlying or associated
with these inherited differences in stress responses.
5
Eight years ago,we decided to adopt a complementary
approach through detection of the most divergent strains
with respect to anxiety-related behaviors among com-
mercially available inbred rat strains.Given the amount
of evidence linking stress-related behaviors,and particu-
larly anxiety,to central serotonergic systems,some of the
key features of these systems in the divergent strains
selected were compared under basal and stress conditions.
We complemented this strategy by comparing the behav-
ioral and neurochemical effects of psychotropic drugs,
especially serotonergic and/or noradrenergic antidepres-
sants,with and without repeated stress exposure.Finally,
our most recent work,which will also be presented below,
somewhat differed from our initial studies in that the
inbred rat strains were selected on the basis of a neuro-
chemical trait, ie, the serotonin transporter (5-HTT),
rather than a behavioral trait.
Anxiety-related behaviors in 
inbred rat strains
Male and female rats were selected from six inbred strains
(the Fischer 344 rat [F344], the Lewis rat [LEW], the
Brown Norway rat, the Wistar-Kyoto rat [WKY], the
spontaneously hypertensive rat [SHR],and the Wistar-
Furth rat) and the behaviors of these animals in several
stressful environments were recorded.
6These included the
open field,the elevated plus-maze,the social interaction
test,and the black and white box,ie,models thought to
allow a correct estimation of independent behavioral
dimensions such as anxiety and locomotion.
7A principal
component (multivariate) analysis allowed us to dissect
the ethological meaning of the behaviors measured in
each test.In addition,our study allowed us to select two
strains of rats (SHR and LEW),which differed selectively
for anxiety-related behaviors in the elevated plus-maze
(open arm visits),the black and white box (visits to the
white compartment),and the open field (visits to the cen-
tral squares),but not for locomotor-related behaviors in
any test (a finding that was later confirmed by locomotion
monitoring in activity cages).Thus,SHR and LEW were
found to display low and high anxiety,respectively,and
the difference between them was devoid of any contami-
nation by activity-related inputs.
Next,we investigated the inheritance of a number of anx-
iety-related behaviors in SHR and LEW.
8To do so,breed-
ing and crossbreeding experiments were conducted to
obtain,for each sex,the parental strains and the F1 and
F2 generations derived from SHR/LEW and LEW/SHR
matings.Thereafter,all 267 individuals were tested in the
elevated plus-maze and the open field,and inheritance
calculations made to determine the origins of the behav-
ioral strain differences.It was found that the most herita-
ble difference between strains was the anxiety-related
number of visits to the center of the open field.This was
due to a direct effect of the genes,rather than to indirect
maternal and grandmaternal effects.The use of micro-
satellites covering the whole genome confirmed this by
revealing a quantitative trait locus in the F2 population
that explained half of the variance associated with the vis-
its to the center of the open field.
9 Interestingly,this locus
was located in the same region of chromosome 4 where
the genes encoding the substance P receptor (Tac1r) and
neuropeptide Y (Npy) have been located. Additional
experiments suggested that neuropeptide Y may be
excluded,leaving open the possibility that an allelic vari-
ation in the gene encoding the substance P receptor par-
ticipates in this behavioral difference found between SHR
and LEW.
Central serotonergic systems in SHR and LEW
under basal and stress conditions
Anatomical,behavioral,and pharmacological data sup-
port the hypothesis that central serotonin (5-HT) plays a
role in the etiology of anxiety.As an illustration,5-HT has
Selected abbreviations and acronyms
[
3H]8-OH-DPAT [
3H]8-hydroxy-2-(di-n-propylamino)tetralin
F344 Fischer 344 rat
5-HIAA 5-hydroxyindoleacetic acid
HPA  hypothalamo-pituitary-adrenal (axis)
5-HT serotonin (5-hydroxytryptamine)
5-HTT serotonin transporter
LEW Lewis rat
NA noradrenaline
SHR spontaneously hypertensive rat
SSRI selective serotonin reuptake inhibitor
WKY Wistar-Kyoto ratbeen suggested to stimulate unconditioned anxiety,
whereas both stimulatory and inhibitory influences of 
5-HT on conditioned anxiety have been advanced.
10-12 In
1996,ie,at a time when only 5-HT1B receptor knockout
mice had been engineered,we took advantage of the most
recent pharmacological findings indicating that 5-HT1A,
5-HT2A,and 5-HT2C receptors played some role in anxi-
ety to check for strain differences regarding these and
other determinants of 5-HT activity.
13We found that in
vitro central tryptophan hydroxylase activity was higher
in LEW than in SHR; however, ex vivo studies in mid-
brain and hippocampus revealed that the synthesis of 
5-HT and the levels of 5-HT and 5-hydroxyindoleacetic
acid (5-HIAA) did not differ between strains. [
3H]8-
Hydroxy-2-(di-n-propylamino)tetralin ([
3H]8-OH-DPAT)
binding at midbrain 5-HT1A autoreceptors and hippo-
campal 5-HT1A postsynaptic receptors, [
3H]ketanserin
binding at cortical and striatal 5-HT2A receptors, and
[
3H]citalopram binding at midbrain and hippocampal 
5-HT transporters (5-HTT) did not vary between strains.
The inhibition of 5-HT synthesis by 5-HT1A autoreceptor
stimulation was similar in the two strains, but forepaw
treading was higher and flat body posture after 5-HT1A
postsynaptic receptor stimulation lower in SHR than in
LEW. Finally, head shakes elicited by 1-(4-iodo-2,5-
dimethoxyphenyl)-2-aminopropane and quipazine (a 
5-HT2A receptor–mediated response) were increased in
the SHR strain compared with the LEW strain; on the
other hand,1-(3-chlorophenyl)piperazine triggered simi-
lar 5-HT2B/2C receptor–mediated decreases in motor
activity in the two strains.
This study thus showed that, although the low-anxiety
strains (SHR) and high-anxiety strains (LEW) vary in
terms of some aspects of 5-HT function, key anxiety-
related components of central serotonergic systems (such
as the 5-HT1A autoreceptors) were no different. Of
course,this result could be explained by the fact that the
tools used at that time were insufficient or not sensitive
enough to thoroughly explore central serotonergic activ-
ity.However,we should not dismiss the possibility that the
basal conditions under which we performed our study
were not the most adequate to reveal strain differences,
if any, in central serotonergic systems. In keeping with
such a hypothesis,we then explored these systems under
stimulated conditions.
Social stress by repeated defeat has been shown to be
endowed with neuroendocrine and behavioral effects that
render this stress model useful to identify adaptive mech-
anisms.
14,15Among these mechanisms,those related to cen-
tral serotonergic systems (eg,hippocampal 5-HT1A and
cortical 5-HT2A receptors)
16 have been particularly under-
lined. Nonetheless (i) how the neuroendocrine and
behavioral effects of social stress are affected by the
genetic status of the animal,and (ii) how this status affects
the relationships between central serotonergic systems
and adaptive processes,have not been studied.We thus
analyzed the effects of repeated defeat by Long-Evans
resident rats (30 min of social defeat followed by 14-18 h
of sensory contact with the aggressor daily for 7 days)
upon the psychoneuroendocrine profile of SHR and
LEW.
17 Repeated defeat time-dependently decreased
body weight growth and food intake in both strains,but
these decreases were more severe and longer-lasting in
the LEW strain.This strain-dependent difference could
not be accounted for by differences in physical contacts
with the resident rats because the number of attacks and
their latency throughout the stress period were similar for
the two strains.When exposed to an elevated plus-maze
test of anxiety, the unstressed LEW entered the open
arms less than their SHR counterparts,thus confirming
above findings.This difference was amplified by social
stress,which increased anxiety-related behaviors in LEW
only.In the forced swimming test,LEW spent more time
immobile than SHR,with stress increasing immobility in
a strain-independent manner.
In addition to the metabolic changes described above,the
activity of the hypothalamo-pituitary-adrenal (HPA) axis
was slightly stimulated in a strain-independent manner by
the stressor,as indicated by increased corticosterone lev-
els and adrenal weights,and decreased thymus weights.In
LEW, but not in SHR, midbrain 5-HT metabolism was
increased by stress and this difference was associated with
an increased Bmax (maximum binding capacity) value for
cortical [
3H]ketanserin binding at the 5-HT2A receptors.
On the other hand, the Bmax value for hippocampal 
[
3H]8-OH-DPAT binding at the 5-HT1A receptors was
decreased by stress,and this reduction was amplified in
SHR compared with LEW. This study illustrates how
genetics may impact the psychoneuroendocrine response
to stress,and the use of socially stressed SHR and LEW
may be an important paradigm in the study of adaptive
processes.
This possibility was explored by measuring the impact of
a 3-week period of treatment with the selective serotonin
reuptake inhibitor (SSRI) fluoxetine (7.5 mg/kg/day) on
the psychoneuroendocrine profiles of stressed LEW (the
Basic research
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SHR strain was not included in this study due to the
amount of effort required for a thorough analysis of a sin-
gle strain).
18 In this series of experiments,social stress con-
sisted of a single overnight exposure to the resident rat
(because the study described above revealed that the first
exposure caused marked behavioral impacts).A single
social defeat triggered hypophagia and body weight loss,
and increased anxiety in the elevated plus-maze.It did not
affect baseline plasma adrenocorticotropic hormone lev-
els or renin activity,but decreased plasma corticosterone
levels.On the other hand,the responses of these variables
to subsequent acute forced swim stress were blunted (cor-
ticosterone) or amplified (adrenocorticotropic hormone,
renin activity) by prior defeat.The density of hippocam-
pal 5-HTTs,but not that of hippocampal 5-HT1A and cor-
tical 5-HT2A receptors,was decreased by a single social
defeat;in addition,tryptophan availability,5-HT synthe-
sis and metabolism,and 5-HT1A autoreceptor–mediated
functions (inhibition of 5-HT synthesis and hyperphagia)
were unaffected.However,it was of note that fluoxetine
pretreatment diminished social defeat–induced hypopha-
gia,body weight loss,and anxiety without affecting these
variables in control animals.This pretreatment increased
plasma corticosterone levels in resting and acutely
stressed rats, but abolished social defeat–elicited corti-
costerone hyporesponsiveness to acute forced swim stress.
Except for a decrease in midbrain 5-HTT density,fluox-
etine did not affect the other serotonergic indices ana-
lyzed.
Taken together,our results show that a single social defeat
in LEW produces behavioral and endocrine alterations
that may model some aspects of human anxiety disorders,
especially posttraumatic stress disorder
19;furthermore,our
finding that repeated SSRI pretreatment has protective
effects on some of the negative consequences of social
stress opens future possibilities for determination of the
precise mechanisms responsible for these consequences.
Genetic variability in the psychoneuro-
endocrine responses to antidepressant 
treatment
While the above experiments were in progress,we came
across findings indicating that the SHR and the WKY
strains markedly differed in their behavioral sensitivities
to tricyclic antidepressants (desipramine and imipramine)
on exposure to the forced swimming test.These agents
decreased the duration of immobility in SHR, but
proved ineffective in WKY.
20,21 Moreover, human data
indicate that the efficacy of antidepressants has a strong
genetic substrate, partly through the allelic variation in
the activity of drug-metabolizing enzymes such as the
cytochrome P450.
22 Our preliminary observation that
SHR and WKY differ in both their anxiety profile (these
strains display low and high anxiety scores,respectively)
and their activity profile (these strains display high and
low activity scores, respectively) led us to analyze their
psychoneuroendocrine responses to several antidepres-
sants.Thus,in one study,repeated fluoxetine treatments
(5 or 10 mg/kg intraperitoneally [IP] daily, for 3 weeks)
were administered to control SHR and WKY, whereas,
in another study, repeated fluoxetine treatments were
compared with imipramine and desipramine treatments
(all 10 mg/kg orally daily,for 4 weeks).Both these stud-
ies were carried out in control and repeatedly stressed
SHR and WKY (2 h of restraint daily throughout the 4th
week).
Repeated fluoxetine treatment 
in control SHR and WKY
Two days after the last fluoxetine injection in the control
experiments,
23 the two strains had undetectable plasma
levels of fluoxetine,but detectable and similar levels of its
metabolite, norfluoxetine.The elevated plus-maze test
(29-30 h after the 13th administration of fluoxetine) and
an open field test (48 h after the last injection of fluoxe-
tine) were used to show that fluoxetine pretreatment did
not produce anxiolysis;hence,some,but not all,behaviors
were indicative of anxiety and hypolocomotion (as
assessed through principal component analyses and acute
diazepam studies).In both strains,the 10 mg/kg dose of
fluoxetine decreased hypothalamus 5-HT and 5-HIAA
levels, and reduced midbrain and/or hippocampus
[
3H]citalopram binding at 5-HTTs, but did not affect
[
3H]8-OH-DPAT binding at hippocampal 5-HT1A recep-
tors. However, the fluoxetine-elicited reduction in hip-
pocampal 5-HTT binding,which was unlikely to be due
to residual norfluoxetine,was much greater in WKY than
in SHR, and this strain-dependent effect in WKY was
associated with a reduction in cortical [
3H]ketanserin
binding at the 5-HT2A receptors. Finally, in WKY,
repeated fluoxetine administration increased adrenal
weights and the plasma corticosterone response to open
field exposure,but did not affect the binding capacities of
hippocampal mineralocorticoid and glucocorticoid recep-tors.Beside the complex neurochemical results that are
beyond the scope of the present survey,our study mainly
illustrates how key psychoneuroendocrine responses to
repeated fluoxetine administration may be strain-depen-
dent.On the other hand,our data contradicted previous
neurochemical and behavioral findings,as illustrated by
our failure to detect anxiolysis after repeated SSRI
administration.
24
Although the results of this control study provide some
positive information,we felt that it was far too limited in
its design: a single antidepressant was administered IP
(instead of orally as in clinical psychiatry) to unstressed
control rats, ie, very different conditions from those
required to assess the potential psychoneuroendocrine
benefit of the psychotropic agent. This is why we per-
formed a second series of experiments with imipramine
and desipramine that took into account the limits of the
first paradigm.
25
Repeated fluoxetine treatment in SHR and
WKY receiving imipramine and desipramine
In the imipramine and desipramine experiments, it was
observed that following a 24-h wash-out period,WKY
displayed higher plasma antidepressant and antidepres-
sant metabolite levels than SHR. Fluoxetine pretreat-
ment decreased [
3H]citalopram binding at midbrain 5-
HTTs, whereas tricyclic antidepressants and fluoxetine
decreased [
3H]ketanserin binding at cortical 5-HT2A
receptors,[
3H]CGP-12177 binding at cortical β-adreno-
ceptors, and [
3H]nisoxetine binding at midbrain nora-
drenaline (NA) transporters in both strains.None of the
antidepressants affected [
3H]8-OH-DPAT binding at
hippocampal 5-HT1A receptors. It was notable that
repeated restraint triggered a desipramine-sensitive
140% increase in hypothalamus [
3H]nisoxetine binding
in WKY, but not in SHR; moreover, plasma adrenocor-
ticotropin-releasing hormone responses to a 5-min open
field test were amplified by prior repeated restraint in
both strains, but desipramine prevented such an ampli-
fication in WKY only.However,the elevated plus-maze
and open field behaviors of SHR and WKY were unaf-
fected by desipramine pretreatment.
A simple conclusion of these experiments is that they
clearly show that the SHR and WKY strains may be use-
ful in understanding how genetic differences in nora-
drenergic responses to stress and desipramine treatment
impact on adaptive processes.
Genetic variability in the rat 5-HTT
The experiments described above all focused on one main
question: do individuals that differ in their behavioral
responses to novel environments also differ with respect
to key central monoaminergic responses to stressors
and/or antidepressants? The results underline how com-
parisons between rat strains may allow the detection of
models of some value for understanding the basis of the
interindividual variability in fear responses,whether these
are linked to behavior (eg,the socially stressed LEW) or
neurochemistry (eg,the restrained WKY).
The quest for the mechanisms explaining such strain-
dependent characteristics undoubtedly require intense
effort, at least effort that is beyond the scientific and
human capacities of our research group.Accordingly,we
recently decided to change our scientific goals by trying
to focus on the genetics of central serotonergic systems,
leaving behavioral and neuroendocrine research topics
aside, at least in the preliminary stages of research. In
other words,we decided to explore whether we could find
strains of rats that differ with respect to one candidate tar-
get,ie,the 5-HTT.If this is successful,it will be followed
by an intense investigation on the psychoneuroendocrine
consequences of such a genetic difference.
Considering that 5-HTT knockout mice already exist,
26-28
why is our investigation in rats so important? The follow-
ing points encouraged us to follow our line of research:
• Constitutive knockout models may be seen as all-or-
nothing paradigms,which impede any quest on the con-
sequences of subtle (ie, <50%) differences in gene
expression.
•Adaptive processes and features linked to the genetic
background of the mouse strains are trivial limits of
these models.
•The use of individuals that differ in terms of the gene of
interest,and also in other genes (as found using differ-
ent strains),may help further define the regulatory links
between the gene of interest and other unexpected
genes.
• Some knockout models may be difficult to use due to
their limited availability and/or the structures needed to
breed them.
In humans,the 5-HTT gene is highly polymorphic,as illus-
trated by allelic variations in the second intron and the
upstream promoter region.
29,30 Data regarding the pro-
moter region suggest that polymorphisms in that region
lead to differences in the 5-HT reuptake function of the
Basic research
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5-HTT.
30Thus,the insertion/deletion of 14 and 16 copies
of a 20- to 23-basepair repeat element leads to two pro-
moter variants,the short and the long variants.When stud-
ied by means of reporter gene constructs and human lym-
phoblasts, the short variant was found to trigger, in a
dominant manner,reductions in 5-HTT transcription and
5-HT reuptake,compared with the long variant.
30When
examined ex vivo,however,peripheral and central 5-HTT
densities and/or 5-HT reuptake did not always obey
allelic variation.
31The initial finding that the short variant
was associated with neuroticism
30 substantiated the
hypothesis that the 5-HTT plays a role in the susceptibil-
ity to mood disorders.Subsequent studies both confirmed
and refuted this initial finding;the diverging results could
be accounted for by the low weight of the 5-HTT gene in
some personality trait differences.
32
The only currently available rodent models of 5-HTT
gene alterations are:
• Mice bearing a 100% constitutive invalidation of their
5-HTT gene.
26-28
• Rats injected in their dorsal raphe with recombinant
plasmids containing the sequence (overexpression) or a
partial antisense (underexpression) sequence of the 5-
HTT gene.
33
• Rat sublines differing in terms of the platelet 5-HTT
gene and protein expression as well as platelet 5-HT
reuptake.
34
The most relevant model of invalidated mice for the study
of the functional consequences of human 5-HTT poly-
morphisms is the comparison between control and het-
erozygote mice;however,heterozygote mice do not dis-
play any difference in 5-HT reuptake compared with
controls,although,logically,5-HTT densities are reduced
by 50%.
26With regard to transgenic rats,the observation
that gene transfers were performed after development
only had transient consequences on 5-HTT and 5-HT
reuptake underlines the limits of that particular model.
33
Finally,autoradiographic experiments conducted with the
rat sublines differing for platelet 5-HTT protein expres-
sion and function suggest that these two sublines may not
differ with regard to central 5-HTT protein expression.
34
Detection of strain differences in 5-HTT: 
behavioral response
Taking into account these observations, we performed
two series of experiments.The first series of experiments
took advantage of the finding that WKY do not respond
acutely to the tricyclics imipramine and desipramine when
examined in the forced swimming test.Thus,one hypoth-
esis could be that 5-HTT and/or NA transporters are
hyposensitive to the 5-HT reuptake (imipramine) and NA
reuptake (imipramine and desipramine) inhibitory prop-
erties of these antidepressants.Accordingly,we used in
vitro,in vivo,and ex vivo methods to examine the 5-HTT
in WKY,SHR,and LEW.
35Acute administration of the
SSRI citalopram (1-10 mg/kg,IP 1 h before an elevated
plus-maze test) to SHR,LEW,and WKY promoted anx-
iety and/or hypoactivity in SHR and LEW, but not in
WKY.This initially reinforced the hypothesis that WKY
5-HTTs are hyposensitive to drugs endowed with 5-HT
reuptake properties. However, the pretreatment with
citalopram increased central 5-HT levels and/or decreased
5-HIAA levels in all strains.Hippocampal,but not mid-
brain or striatal,[
3H]citalopram binding at 5-HTTs was
lower in WKY than in SHR,whereas the [
3H]5-HT reup-
take kinetics and the potencies of citalopram (1-1000 nM)
needed to inhibit [
3H]5-HT reuptake into hippocampal
and striatal synaptosomes did not differ between strains.
This was confirmed in vivo by means of microdialysis in
the hippocampus of freely moving rats.Thus, although
LEW displayed a three- to fourfold higher baseline level
of extracellular 5-HT in the hippocampus,compared with
SHR and WKY, local perfusion with 1 µM citalopram
promoted relative increases in extracellular 5-HT levels
over baseline that were similar in all strains. Acute IP
administration of 3.3 mg/kg citalopram (1 h beforehand)
decreased [
3H]5-HT reuptake into hippocampal synapto-
somes to a similar extent in SHR and WKY,thereby indi-
cating that the systemic administration of the SSRI has
strain-independent effects at hippocampal 5-HT nerve
terminals.This study thus failed to detect strain differ-
ences in the 5-HTT or in its sensitivity to an SSRI,further
indicating that genetic differences in the behavioral
responses to SSRIs may involve 5-HTT–independent
mechanisms.
Detection of strain differences in 5-HTT: 
5-HT reuptake
With this negative finding in mind,we returned to a com-
parison of the six inbred rat strains mentioned at the
beginning of this report (F344,LEW,Brown Norway rat,
WKY,SHR,and Wistar-Furth rat),to which were added
two standard rat strains, namely the Wistar and the
Sprague-Dawley strains. This time hippocampal 5-HTreuptake,instead of anxiety-related behavior,was taken
as the criterion of selection.We observed that F344 rats
displayed the highest rates of reuptake,while LEW were
among those with the lowest.An analysis of various ele-
ments of central serotonergic systems in female F344 and
LEW had previously indicated that 5-HTT mRNA was
more abundant in the dorsal raphe nucleus of F344,com-
pared with LEW.
36 This suggests that differences in
mRNA expression underlie our observation of strain dif-
ferences in protein function.We therefore performed a
complete study of the central and peripheral 5-HTT in
both sexes of both strains (manuscript submitted for pub-
lication).Indeed,midbrain and hippocampal [
3H]paroxe-
tine binding at the 5-HTT and hippocampal [
3H]5-HT
reuptake were increased in male and female F344,com-
pared with their LEW counterparts,and these strain dif-
ferences were observed both in rats of commercial origin
and in laboratory-bred rats (thus excluding strain differ-
ences linked to late environment changes).
3 Moreover,in
laboratory-bred rats,it was found that these strain differ-
ences extended to blood platelet 5-HTT protein expres-
sion and function.Saturation studies of midbrain and hip-
pocampal [
3H]paroxetine binding at 5-HTT, and
hippocampal and blood platelet [
3H]5-HT reuptake,also
revealed slight,but significant,strain differences in Bmax
and Vmax (maximal velocity) values.Although F344 and
LEW differ in terms of the activity of the HPA axis,
37,38
experiments conducted in male rats that had been
adrenalectomized or treated with corticosterone revealed
that the strain differences in hippocampal [
3H]paroxetine
binding at 5-HTTs and [
3H]5-HT reuptake were not
accounted for by the HPA axis.Systemic administration
of the SSRI citalopram decreased midbrain and hip-
pocampal 5-HT turnover rates,the amplitudes of which
varied in a strain-independent manner.Conversely,hip-
pocampal extracellular 5-HT levels were reduced in F344,
compared with LEW,but the magnitude of the increase
in extracellular 5-HT elicited by local administration of
citalopram was larger in F344.Finally,at the molecular
level,no strain differences were found in the respective
coding sequences of the 5-HTT gene,thus suggesting that
genetic differences,if any,lie in the promoter region (note
that,as opposed to mice and humans,the rat 5-HTT gene
promotor has not yet been cloned).
Taken together,the results of this series of experiments
indicate that the F344 and LEW strains will be useful in
the study of the impact of genetics on 5-HTT and how
allelic control of 5-HTT (which remains to be demon-
strated) affects stress responses.
Conclusion
This short survey of our most recent experiments aimed
to illustrate how the use of different inbred rat strains is
a positive complementary approach to already existing
transgenic models.However,such a strategy requires ade-
quate criteria for selection,especially regarding behav-
ioral traits. In this respect, we show that multivariate
analyses can be used to remove contaminant behaviors.
This strategy therefore measures the impact of stressors
and/or antidepressants in animals that are genetically
prone to display hypersensitivity to fear-related events.
This is illustrated by our proposal that the socially stressed
LEW is an appropriate model of posttraumatic stress dis-
order,whereas the WKY may prove important in future
studies into the genetic basis of the hypersensitivity of
central noradrenergic systems to stress and NA-related
tricyclics.Our results in LEW also underline the need to
use ethologically relevant models of stress,such as social
stress,rather than aversive stressors without any clearcut
relevance to humans (eg,electric shocks).The final series
of experiments described above illustrate how a strategy
based on an initial screening of inbred rat strains applies
to key neurochemical targets,such as the 5-HTT,thereby
filling a gap in the animal models currently available for
the study of the consequences of human allelic variations
in 5-HTT.This survey was never intended to indicate that
a comparison between inbred rat strains is the most valu-
able strategy,but rather to show that it is a valuable com-
plement to currently existing models, most of which
involve the use of transgenic strategies in mice. ❏
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Neurogenética de la reactividad emocional al estrés en los animales
Existe bastante evidencia acerca del compromiso de los sistemas monoaminérgicos centrales –los blancos clave
del estrés– en la regulación del ánimo. Los hallazgos en animales y humanos indican que la genética juega un
papel en la etiología de los trastornos del ánimo, y por eso se seleccionaron cepas puras de ratas que se dife-
rencian según sus conductas relacionadas con la ansiedad y la exposición a nuevos ambientes. Se compararon
estas cepas respecto a la respuesta psiconeuroendocrina a estresores y/o antidepresivos. También se realiza-
ron estudios de genética molecular para localizar las regiones genómicas asociadas con estos perfiles de ansie-
dad dependientes de la cepa. Luego se examinaron los resultados en humanos, los cuales indican que las varia-
ciones alélicas en el transportador de serotonina (T 5-HT) pueden jugar un papel en la etiología del neuroticismo
y la depresión. De este modo, se compararon cepas puras de ratas para el T 5-HT, en relación con la expresión
y función de proteínas centrales y periféricas (plaquetas), y las consecuencias de la aplicación local de un inhi-
bidor selectivo de la recaptación de serotonina (ISRS) en los niveles extracelulares de serotonina (5-HT). Nuestros
resultados indican que las ratas espontáneamente hipertensas y las ratas de Lewis (LEW) difieren selectivamente
respecto a las conductas relacionadas con la ansiedad y que esta diferencia se localiza en el cromosoma 4. El uso
del rechazo social en las ratas LEW y el análisis de sus consecuencias psiconeuroendocrinas sugieren fuertemente
que este paradigma, que es sensible a un tratamiento repetido con ISRS, constituye un modelo para el trastorno
por estrés postraumático. La rata Wistar-Kyoto puede constituir un modelo adecuado para estudiar las conse-
cuencias de una hipersensibilidad al estrés y a los antidepresivos noradrenérgicos genéticamente determinada.
Nuestros hallazgos más recientes muestran que las cepas Fischer 344 y LEW se diferencian en la expresión de
proteínas y en la función del transportador de serotonina en el hipocampo y las plaquetas; la diferencia en la
expresión de proteínas no se debe a las variaciones alélicas en las secuencias codificadoras de genes, y conduce
a diferencias marcadas en los niveles de 5-HT extracelular en condiciones basales o con ISRS. Estos ejemplos ilus-
tran cómo el empleo de cepas puras de ratas pueden ayudar a nuestro conocimiento acerca de la genética
del comportamiento, al igual que la utilización de los ratones transgénicos.
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Neurogénétique de la réactivité émotionnelle au stress chez l’animal
La participation des systèmes monoaminergiques centraux, cibles-clés du stress, dans la régulation de l’humeur,
est largement prouvée. Les résultats chez l’homme comme chez l’animal montrent que la génétique joue un
rôle dans l’étiologie des troubles de l’humeur, ce qui nous a amenés à sélectionner des lignées pures de rat dont
le comportement lié à l’anxiété diverge après exposition à de nouveaux environnements. Nous avons comparé
la réponse neuro-psycho-endocrinienne de ces lignées à certains facteurs de stress et/ou antidépresseurs. Des
études de génétique moléculaire ont également été conduites afin de localiser les régions génomiques asso-
ciées aux profils anxieux liés à ces lignées. Nous avons examiné ensuite les résultats chez l’homme qui montrent
que les variations alléliques dans le transporteur sérotoninergique (5-HTT) peuvent jouer un rôle dans l’étio-
logie des comportements névrotiques et de la dépression. Nous avons donc comparé des lignées pures de rats
pour le 5-HTT, en ce qui concerne l’expression et la fonction des protéines périphériques (plaquettes) et cen-
trales, et les conséquences de l’application locale d’un inhibiteur sélectif de la recapture de la sérotonine (ISRS)
sur les concentrations de sérotonine extracellulaires (5-HT). Nos résultats montrent une divergence sélective
entre les rats spontanément hypertendus et les rats Lewis (LEW) en termes de comportements liés à l’anxiété,
cette divergence étant située sur le chromosome 4. Le comportement social des rats LEW devant l’échec et l’ana-
lyse de ses conséquences neuro-psycho-endocriniennes suggèrent fortement qu’un tel paradigme, sensible au
traitement répété par ISRS, constitue un modèle pour l’état de stress posttraumatique. Le rat Wistar-Kyoto peut
servir de modèle pour l’étude des conséquences d’une hypersensibilité au stress et aux antidépresseurs nora-
drénergiques génétiquement induite. Nos résultats les plus récents montrent que les lignées Fischer 344 et LEW
diffèrent aux niveaux de l’expression et de la fonction protéiques du 5-HTT  hippocampique et plaquettaire ; la
divergence dans l’expression protéique n’est pas due aux variations alléliques dans les séquences codées par
gènes et entraîne des différences importantes dans les concentrations extracellulaires de 5-HT en conditions
basales ou sous ISRS. Ces exemples montrent que l’utilisation de lignées pures de rats peut compléter nos connais-
sances sur la génétique des comportements, de  même que l’utilisation des souris transgéniques.
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